Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $7 | $3 | $4 | $5 |
| - Cash | $4 | $4 | $4 | $4 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $4 | $1 | $1 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 20.5% | 0.2% | 18% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 66.1% | 66.6% | 64.1% | 68.1% |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 26.5% | -29.4% | 12% | -16% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 9% | -19.3% | -3.5% | -0.5% |
| EPS Diluted | 0.011 | -0.02 | -0.004 | -0.001 |
| % Growth | 156.6% | -450% | -620% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |